慢性自发性荨麻疹患者旅程建模:通过缩短患者疾病旅程提高德国患者的认知与教育
该研究通过文献综述和专家会议梳理德国慢性自发性荨麻疹(CSU)患者的旅程,并建立概率模型模拟三种改进策略的影响。模拟显示德国CSU患者平均需3.8年达到疾病控制,三种优化策略联合可缩短至2.5年;人群水平疾病控制比例从44.2%升至58.1%。结论认为有效药物和指南已存在,但实践落实滞后。
要点
- 德国CSU患者平均需3.8年达到疾病控制,存在诊断和最佳医疗照护延迟。
- 联合患者教育、医务人员教育项目和疾病管理项目可使控制时间缩短至2.5年。
- 人群水平疾病控制比例从44.2%升至58.1%。
核心结论
- 有效CSU药物和疾病特异性指南已存在,但临床实践中推荐落实滞后。
- 患者旅程定量建模验证了障碍,并显示多种干预对患者旅程有明确效果。
研究设计与样本
- 通过文献综述和包括医学专家、药师及患者组织代表的专家会议追溯德国CSU患者旅程。
- 采用共同创造方法开发概率模型,模拟三种潜在改进策略的影响。
主要发现
- CSU患者因诊断和最佳医疗照护延迟而承受严重负担。
- 模拟显示德国CSU患者平均需3.8年达到疾病控制。
- 建模三种优化策略联合后,达到CSU症状控制的时间缩短至2.5年。
- 人群水平上,CSU患者疾病控制比例从44.2%增加至58.1%。
关键数值与推荐
- 三种潜在改进策略为:患者教育运动、医务人员教育项目和疾病管理项目(DMP)实施。
临床怎么用
- 模拟数据可用于识别改善患者照护的策略。
- 该方法可能有助于理解和改善CSU以外患者的管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic spontaneous urticaria (CSU) is both physically and emotionally stressful, and guideline recommendations are often not optimally implemented in clinical practice. The objective of this study was to provide an overview on the patient journey in CSU and to develop a mathematical model based on solid data. METHODS: The journey of CSU patients in Germany was traced through literature review and expert meetings that included medical experts, pharmacists and representatives of patient organizations. The current situation's main challenges in the patient journey (education, collaboration and disease management) were discussed in depth. Then, a probabilistic model was developed in a co-creation approach to simulate the impact of three potential improvement strategies: (1) patient education campaign, (2) medical professional education programme and (3) implementation of a disease management programme (DMP). RESULTS: Chronic spontaneous urticaria patients are severely burdened by delays in diagnosis and optimal medical care. Our simulation indicates that in Germany, it takes on average of 3.8 years for patients to achieve disease control in Germany. Modelling all three optimization strategies resulted in a reduction to 2.5 years until CSU symptom control. On a population level, the proportion of CSU patients with disease control increased from 44.2% to 58.1%. CONCLUSIONS: In principle, effective CSU medications and a disease-specific guideline are available. However, implementation of recommendations is lagging in practice. The approach of quantitative modelling of the patient journey validates obstacles and shows a clear effect of multiple interventions on the patient journey. The data generated by our simulation can be used to identify strategies for improving patient care. Our approach might helping in understanding and improving the management of patients beyond CSU.
引用
- Maurer M, Augustin M, Bauer S, et al. Modelling of patient journey in chronic spontaneous urticaria: Increasing awareness and education by shorten patients' disease journey in Germany. J Eur Acad Dermatol Venereol. 2024. PMID: 38441370. doi:10.1111/jdv.19940
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。